Pricing
  1. US-listed companies
  2. Avid Bioservices, Inc.
  3. Financials
  4. Revenue

Avid Bioservices, Inc. (CDMO)

Market cap
$798.9M
P/E ratio
SummaryFinancials
Period EndRevenue (Million USD)YoY (%)
Apr 30, 2024140-6.27%
Apr 30, 2023149+24.81%
Apr 30, 2022120+24.75%
Apr 30, 202196+60.58%
Apr 30, 202060+11.38%
Apr 30, 201954-0.03%
Apr 30, 201854-6.96%
Apr 30, 201758+28.97%
Apr 30, 201645+66.86%
Apr 30, 201527+19.55%
Apr 30, 201422+3.31%
Apr 30, 201322+42.34%
Apr 30, 201215

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat